As the VP, Head of Global Market Access, Cell Therapy at BMS, Phung brings over 30 years of experience in building market access and payer teams through strategic positioning and customer-focused solutions. Her career has been dedicated to bringing innovative medications to market, spanning from autoimmune to hematologic disorders.
Phung has been a leader across the U.S. healthcare system, adeptly navigating access to care and medication for rare diseases. Her diverse experience spans across companies such as JNJ, Baxter, Iovance, Orca Bio, and Prime Therapeutics.